As part of the company’s continuing initiative to expand its global presence, PharmEng Technology (PharmEng) has merged with Pharmaceutical Validation Compliance Group (PVCG) to increase its capability to serve European clients.

Marking another historic milestone for PharmEng’s global expansion initiative, PharmEng Technology announced that it has completed a merger with PVCG, based in Cork, Ireland. Both companies focus on providing engineering support and compliance solutions to clients in the Life Science Industries. The merging of  PharmEng and PVCG will provide better and more efficient service to their clients under the PharmEng umbrella.

Commenting on the recently completed acquisition, Alan Kwong, CEO of PharmEng said, “PharmEng shares a similar mission, common values, and mindset with PVCG for supporting the solution needs of clients within the Life Sciences industry. This acquisition advances PharmEng’s singular goal to align our solutions and services in a manner that best accommodates and meets the needs of our global target market with maximum efficiency.” 

Kwong’s comments are echoed by Kevin Dempsey, President of PVCG, who noted,“Joining PharmEng will greatly enhance and expand the service of PVCG to the local and multinational clients in a more efficient manner.” 

With over 300 staff in 12 offices located in Asia, Europe, Latin America, and North America, this merger allows PharmEng Technology to continue to serve global clients with local presence, adding to its proven track record of providing the highest quality solutions to its clients.

For more information, visit www.pharmeng.com or email info@pharmeng.com for any inquiries.